News
-
-
-
COMMUNIQUÉ DE PRESSE
Eurobattery Minerals publishes Q2 report for 2025 at the same time as it launches work at the San Juan Tungsten Project
Eurobattery Minerals AB publishes Q2 2025 interim report showcasing strategic projects in Europe for critical raw materials supply. Financial highlights and key developments included -
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)
Napo Pharmaceuticals plans FDA meeting to discuss crofelemer clinical program for MVID, with proof-of-concept results reducing TPN. Abstract accepted for NASPGHAN 2025 Annual Meeting in Chicago -
COMMUNIQUÉ DE PRESSE
Sekur Private Data Ltd. Signs Distribution Agreement with Rich TV to Promote Sekur Privacy Solutions
Sekur Private Data Ltd. partners with RichTV.io to promote Swiss-hosted privacy solutions to crypto and privacy enthusiasts. The partnership aims to increase awareness of Sekur's secure communication tools -
COMMUNIQUÉ DE PRESSE
Strategic Metals samples 2740 g/t silver and 8.37 g/t gold at its Triple Crown Project, Yukon
Strategic Metals Ltd. reports favorable exploration results at Triple Crown Project in Yukon, including high silver values. Geological work indicates potential for silver- and gold-rich epithermal veins alongside copper-gold system -
COMMUNIQUÉ DE PRESSE
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
MIRA Pharmaceuticals, Inc. announces successful completion of Phase 1 Single Ascending Dose trial for oral Ketamir-2, preparing for U.S. Phase 2a trial in Q4 2025 -
